🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 21 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/02/2006 | 32,16 | 32,82 | 32,02 | 32,15 | -0,41% | 2,49% | 7.069.598 |
| 06/02/2006 | 32,67 | 32,72 | 32,19 | 32,28 | -1,63% | 1,61% | 7.084.794 |
| 03/02/2006 | 32,92 | 33,05 | 32,27 | 32,81 | +1,69% | 2,38% | 10.910.099 |
| 02/02/2006 | 32,97 | 33,14 | 32,16 | 32,27 | -2,42% | 2,98% | 11.172.099 |
| 01/02/2006 | 32,70 | 33,15 | 32,63 | 33,07 | +0,46% | 1,58% | 9.140.132 |
| 31/01/2006 | 33,27 | 33,28 | 32,81 | 32,92 | +0,12% | 1,41% | 15.699.878 |
| 30/01/2006 | 32,83 | 33,06 | 32,50 | 32,88 | -0,69% | 1,71% | 10.537.116 |
| 27/01/2006 | 32,25 | 33,25 | 32,17 | 33,11 | +2,21% | 3,37% | 11.474.971 |
| 26/01/2006 | 31,81 | 32,49 | 31,79 | 32,40 | +2,29% | 2,19% | 11.606.810 |
| 25/01/2006 | 31,20 | 31,72 | 31,06 | 31,67 | +1,25% | 2,11% | 8.512.170 |
| 24/01/2006 | 31,23 | 31,50 | 31,12 | 31,28 | -0,15% | 1,22% | 8.081.128 |
| 23/01/2006 | 31,62 | 31,69 | 31,26 | 31,33 | -1,26% | 1,36% | 8.142.646 |
| 20/01/2006 | 31,79 | 31,90 | 31,50 | 31,73 | -0,21% | 1,26% | 10.625.777 |
| 19/01/2006 | 31,83 | 32,09 | 31,70 | 31,79 | +0,88% | 1,23% | 9.769.875 |
| 18/01/2006 | 31,60 | 31,89 | 31,44 | 31,52 | -0,54% | 1,42% | 9.579.978 |
| 17/01/2006 | 31,59 | 32,11 | 31,50 | 31,69 | -0,78% | 1,93% | 10.750.489 |
| 13/01/2006 | 31,99 | 32,18 | 31,82 | 31,94 | -0,03% | 1,10% | 7.420.259 |
| 12/01/2006 | 32,02 | 32,04 | 31,82 | 31,95 | +0,06% | 0,69% | 7.491.733 |
| 11/01/2006 | 31,96 | 32,05 | 31,78 | 31,93 | +0,39% | 0,84% | 10.005.570 |
| 10/01/2006 | 31,92 | 31,92 | 31,61 | 31,80 | -0,98% | 0,96% | 9.410.411 |
| 09/01/2006 | 31,70 | 32,12 | 31,25 | 32,12 | +1,63% | 2,74% | 16.702.919 |
| 06/01/2006 | 31,57 | 31,83 | 31,36 | 31,60 | -0,18% | 1,48% | 9.776.058 |
| 05/01/2006 | 31,41 | 31,86 | 31,01 | 31,66 | +0,15% | 2,70% | 16.383.908 |
| 04/01/2006 | 31,25 | 31,68 | 31,25 | 31,61 | +1,16% | 1,37% | 13.149.466 |
| 03/01/2006 | 31,03 | 31,36 | 30,35 | 31,25 | +2,95% | 3,26% | 12.185.725 |
| 30/12/2005 | 30,87 | 30,87 | 30,31 | 30,35 | -1,67% | 1,82% | 8.693.160 |
| 29/12/2005 | 30,61 | 31,05 | 30,61 | 30,87 | +1,38% | 1,43% | 8.017.724 |
| 28/12/2005 | 30,57 | 30,72 | 30,34 | 30,45 | -0,09% | 1,22% | 6.786.114 |
| 27/12/2005 | 30,63 | 30,76 | 30,35 | 30,48 | -0,81% | 1,34% | 6.671.778 |
| 23/12/2005 | 30,16 | 30,76 | 30,16 | 30,73 | +0,59% | 1,99% | 5.039.727 |